Log In
BCIQ
Print this Print this
 

PTI-428

  Manage Alerts
Collapse Summary General Information
Company Proteostasis Therapeutics Inc.
DescriptionCystic fibrosis transmembrane conductance regulator (CFTR) amplifier
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation U.S. - Fast Track (Treat cystic fibrosis (CF))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today